Cohance Lifesciences Performance
- Today's Low
- ₹450
- Today's High
- ₹458
- 52 Week Low
- ₹267
- 52 Week High
- ₹1,121
- Open Price₹454
- Previous Close₹451
- Volume114,494
- 50 DMA₹423.78
- 100 DMA₹434.55
- 200 DMA₹530.07
Cohance Lifesciences Chart
Investment Returns
- Over 1 Month + 5.55%
- Over 3 Month + 45.3%
- Over 6 Month -13.42%
- Over 1 Year -52.8%
Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!
Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 96.7
- PEG Ratio
- -2.9
- Market Cap Cr
- 17,340
- P/B Ratio
- 4.4
- Average True Range
- 21.02
- EPS
- 5.16
- Dividend Yield
- 0
- MACD Signal
- 4.47
- RSI
- 57.51
- MFI
- 88.12
Latest Stock News Updates
Conference Call with Cohance Lifesciences Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 1 month 2 weeks ago
Conference Call with Cohance Lifesciences Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 4 months 2 weeks ago
Conference Call with Cohance Lifesciences Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 10 months 2 weeks ago
Cohance Lifesciences Financials
Cohance Lifesciences Technicals
EMA & SMA
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹437.80
- 50 Day
- ₹423.80
- 100 Day
- ₹434.60
- 200 Day
- ₹530.10
Resistance and Support
- R3 485.57
- R2 477.78
- R1 464.47
- S1 443.37
- S2 435.58
- S3 422.27
Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends
About Cohance Lifesciences
- NSE Symbol
- COHANCE
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Cohance Lifesciences
Popular Stocks
Cohance Lifesciences FAQs
Cohance Lifesciences share price is ₹453 As on 02 July, 2026 | 10:58
The Market Cap of Cohance Lifesciences is ₹17339.9 Cr As on 02 July, 2026 | 10:58
The P/E ratio of Cohance Lifesciences is 96.7 As on 02 July, 2026 | 10:58
The PB ratio of Cohance Lifesciences is 4.4 As on 02 July, 2026 | 10:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.